Biomerica EPS BMRA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Biomerica's earnings per share was −$1.63 over the twelve months to Aug 31, 2026.

In its latest quarter, Q1 FY27, it was −$0.37.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q1 FY27	Aug 31, 2026	−$0.37	n/a	−$1.63
Q4 FY26	May 31, 2026	−$0.37	n/a	−$1.26
Q3 FY26	Feb 28, 2026	−$0.44	n/a	−$1.59
Q2 FY26	Nov 30, 2025	−$0.45	n/a	−$1.63
Q1 FY26	Aug 31, 2025	$0.00	n/a	−$1.66
Q4 FY25	May 31, 2025	−$0.70	n/a	−$2.29
Q3 FY25	Feb 28, 2025	−$0.48	n/a	−$2.23
Q2 FY25	Nov 30, 2024	−$0.48	n/a	−$2.63
Q1 FY25	Aug 31, 2024	−$0.63	n/a	−$2.87
Q4 FY24	May 31, 2024	−$0.64	n/a	−$2.80
Q3 FY24	Feb 29, 2024	−$0.88	n/a	−$3.04
Q2 FY24	Nov 30, 2023	−$0.72	n/a	−$3.12

Companies in Healthcare nearest Biomerica's size, closest first, today.

Company	EPS, 12 months	Growth
BMRABiomerica	−$1.63
NEPHNephros	$0.16	+33% a year
ATNMActinium Pharmaceuticals	$0.36
APTAlpha Pro Tech	$0.41	+24% a year
SPROSpero Therapeutics	$0.11
LFVNLifevantage	$0.40	−46% a year
Peer median	$0.36

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.